EuKedos S.p.A. EUK.MI MIL · Healthcare · Italy
0.50 € +0.40% +0.00 €
Summary
25 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- The price moves less than the market (beta 0.23).
What to watch
- Repaying its net debt would take 10.8 years of operating profit.
- Out of every 100 EUR of revenue, only 0.9 EUR is left as net profit.
- It earns only 1.1 EUR a year on every 100 EUR of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 24.9 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
Revenue grew by 1.9% a year over 5 years. Over the last 3 years it grew by 3.2% a year.
Growth in detailDoes it make money?
PoorlyWhere 100 EUR of revenue goes
- Cost of sales 76 EUR
- Sales and administration 13 EUR
- Taxes and other 10 EUR
- Net profit 0.9 EUR
Net profit, industry median (Medical - Care Facilities) 7.2 EUR
Out of every 100 EUR of revenue, 0.9 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 392.1 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail